disCoVer 21 – Highly sensitive lateral flow systems for the detection of viral pathogens

Rapid COVID-19 test for detection of specific antibodies IgM and IgG to novel corona virus SARS-CoV-2 causing Covid-19 illness. Medic or doctor in protective gloves collects blood from patient finger
© tilialucida - stock.adobe.com

In the disCoVer 21 project, a diagnostic test based on PCR-free detection is to be developed. This would eliminate lengthy analysis steps (transcription of RNA into DNA and subsequent PCR), which sometimes lead to long waiting times for a smear result.

Due to a shortened analysis time, infected persons can be identified, isolated and treated more quickly if necessary. At the same time, chains of infection can be better traced in order to further reduce the spread of the virus.

To simplify sample analysis and increase throughput in laboratories, disCoVer 21 targets highly sensitive lateral flow test strips on which the target substances are directly and specifically detected. From the Fraunhofer Institute for Cell Therapy and Immunology IZI the units MicroDiagnostics and Preclinical Validation are working on the project.

Support

This work was supported by the Fraunhofer InternaI Programs under Grant No. Anti-Corona 600020.